Del mismo modo que muchos más bien adornos esta entrada de la Biblia de las Fuentes .
Según la BBC en el medio de los años 80, la biblia se convertiría en el nuevo. New La Biblia De Las Fuentes Conmutadas Tomo 1 Taringa
.Predictors of long-term survival after oesophagectomy for carcinoma of the lower oesophagus or gastro-oesophageal junction: a systematic review.
Oesophagectomy is a well-established treatment for patients with carcinoma of the lower oesophagus or gastro-oesophageal junction. However, survival after oesophagectomy remains low, with many patients having long-term disease-specific survival. In this review, we investigated risk factors for long-term survival after oesophagectomy. An electronic search of the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, the Cochrane Methodology Register, the MEDLINE database, EMBASE and the International Pharmaceutical Abstracts database was conducted. The search was last updated in October 2004. Inclusion criteria were randomised and/or non-randomised controlled clinical studies, including patients with histologically confirmed carcinoma of the lower oesophagus or gastro-oesophageal junction. Trials of neoadjuvant chemoradiotherapy were excluded. Studies were independently reviewed by two authors for study design, definition of prognostic factors, sample size, follow-up, and overall survival and disease-specific survival outcomes. All factors with at least a 10% effect on overall survival were selected for further analysis. Seven studies were included in this review: three randomised controlled trials, one randomised controlled trial protocol, one non-randomised controlled trial and two retrospective studies. No study explicitly compared the effect of neoadjuvant therapy versus primary surgery on overall survival or disease-specific survival after oesophagectomy. None of the studies suggested a benefit of neoadjuvant therapy over primary surgery for overall survival or disease-specific survival after oesophagectomy. One trial suggested a significant decrease in disease-specific survival for patients with nodal involvement compared with those without nodal involvement (P = 0.04). None of the studies suggested a significant association between gender, age, tumour location, differentiation, tumour size, weight loss, post 0b46394aab